Date: 20-Sep-2021

NCLT Approves Merger Of Sun Pharma Global FZE With Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Limited stated that it has received the certified copy of the order passed by the National Company Law Tribunal, Ahmedabad Bench on August 31, 2021, approving the Scheme of Amalgamation and merger of Sun Pharma Global FZE (Transferor Company), an indirect wholly-owned subsidiary of the company with the company (Transferee Company), and their respective members and creditors (Scheme), for the merger of the Transferor Company with the Transferee Company.

“The copy of the certified order of the National Company Law Tribunal, Ahmedabad Bench will be filed along with E form INC-28 by the company with the Registrar of Companies, Ahmedabad, Gujarat and thereafter, the merger will be considered complete, effective from the appointed date as per the Scheme,” the company said.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices